Statistics for iRadimed (id:5324 IRMD)

Valuation metrics

Market cap

674.61M

Enterprise value

623.15M

Trailing P/E (ttm)

36.46

Forward P/E

30.42

PEG ratio

30.42

Price/Sales (ttm)

9.46

Price/Book (mrq)

8.08

Enterprise Value/Revenue

8.74

Enterprise Value/EBITDA

28.13

Overview

Shares outstanding

12.67M

Float

7.11M

Shares short

80.80K

% Held by insiders

0.37%

% Held by institutions

0.57%

Average volume (10 days)

44.88K

Average volume (90 days)

Price summary

52-Week low

40.05

52-Week high

57.95

52-Week change

19.11%

Beta

0.80

50-Day moving average

51.02

200-Day moving average

45.64

Dividends and splits

Forward annual dividend rate

0.60

Forward annual dividend yield

0.01

Trailing annual dividend rate

0.45%

Trailing annual dividend yield

0.01

5-Year annual dividend yield

Payout ratio

0.31

Dividend date

November 25th, 2024

Ex-dividend date

November 15th, 2024

Last split factor

2:1

Last split date

Financials

Fiscal year

Fiscal year ends

December 31th, 2023

Most recent quarter (mrq)

September 30th, 2024

Profitability

Profit margin

26.12%

Operating margin

31.59%

Operational effectiveness

Return on assets

14.67%

Return on equity

23.58%

Income statement

Revenue (ttm)

5.64

Revenue per share (ttm)

5.64

Quarterly revenue growth (yoy)

0.00

Gross profit (ttm)

50.16M

EBITDA

22.15M

Net income to common (ttm)

18.63M

Diluted EPS (ttm)

1.46

Quarterly earnings growth (yoy)

-0.30%

Balance sheet

Total cash (mrq)

51.72M

Total cash per share (mrq)

4.08

Total debt (mrq)

264.08K

Total Debt/Equity (mrq)

0.32

Current ratio (mrq)

921.30%

Book value per share (mrq)

6.58

Cash flow

Cash flow statement

23.55M

Levered free cash flow (LFCF)

13.14M